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Background
Introduction
CMR has become the leading technique to define the
clinical impact of hypertrophic cardiomyopathy (HCM)
providing complete coverage of both ventricles with high
spatial resolution. Gadolinium delayed-enhancement
(DHE) accurately identifies regions of myocardial fibrosis.
Via CMR, innumerable studies have established that LVH
is the predominant phenotypic expression of HCM. It is
well known that myocardial fibrosis can occur in patients
with HCM and is independently linked to a poorer prog-
nosis than those without fibrosis by CMR.
Hypothesis
We hypothesize that there if there is significant RV
involvement in HCM when incorporating a CMR analy-
sis for RV hypertrophy and fibrosis this will have an
independent effect on mortality.
Methods
Review of all patients referred for HCM was performed.
SSFP/DHE was used to diagnose patients with HCM,
using gadolinium administration (0.15mmol/kg, Multi-
Hance, Bracco Diagnostics, Princeton, NJ). Post-injec-
tion (2/10 minutes) DHE images were obtained using
manual T1-weighted, inversion recovery preparations.
Regions of myocardium with abnormally high signals
were designated as fibrotic. LV/RV mass indices (LVMI/
RVMI) and ejection fractions were calculated. Fibrosis
was semi-quantitatively assessed in both ventricles. All
patients will undergo National Death Index search for
mortality.
Results
Via 72 patients referred for HCM from 2007-2013,
47(65.27 %) were CMR confirmed. The mean LVMI was
108 ±44gm2 while the mean RVMI was 30±21 gm2. All
patients met formal LVH criteria while 34/47 (72%) met
RVH criteria. Out of the RVH positive patients, 26/34
(76%) patients were LV LGE positive and 18/34 (52%)
were RV LGE positive. 34/47(72%) had evidence of LV
fibrosis while 24/47 (51%) had evidence for RV fibrosis.
Only 2 patients with RV fibrosis had absent LV fibrosis.
There is a negative correlation between LVH (mean
108±44gm2) and LVEF (67% ±10%) of -0.097. Three of
72 patients died of CV deaths as per NDI with all 3 hav-
ing LV LGE of which 2 had RV LGE (p=NS). Neither
the degree of RV hypertrophy nor the amount of RV
LGE was shown to be predictive of death for the 2 pts
with RV involvement (p=NS).
Conclusions
The frequency of RVH/fibrosis in the setting of HCM is
common especially with the knowledge that this phe-
nomenon is rarely described. Nevertheless, given the
myriad of genetic abnormalities, there is no reason to
expect the phenotypic expression should be limited to
the LV. However, neither the impact of RV hypertrophy
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